Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.

Source:http://linkedlifedata.com/resource/pubmed/id/16501083

Download in:

View as

General Info

PMID
16501083